Delivery Order SPE2DB22D3004-SPE2DB25FQF47

Award Date 4/10/25
Potential Completion Date 4/11/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba FlexTouch 100 Unit/mL 3mL medication. The award has a ceiling value of $1,000.86 and an ultimate completion date of June 3, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,491.38, is for the provision of Tresiba FlexTouch 200 unit/mL 3mL, a diabetes medication. The contract is a firm fixed-price delivery order with a completion date of February 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba FlexTouch insulin medication. The contract, valued at $3,001.59, has a period of performance through November 15, 2024 and utilizes a firm fixed price pricing structure. The award is not designated as a set-aside contract. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a pharmaceutical product, with a ceiling value of $1,392.98 and a period of performance ending on April 4, 2025. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,734.20 and is for the delivery of Tresiba FlexTouch, a medical supply used for the treatment of diabetes. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Tresiba Flextouch 100 Unit/mL 3mL, a diabetes medication. The contract has a ceiling value of $1,861.80 and a period of performance through November 4, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corporation for the supply of Tresiba Flextouch 200 Unit/mL 3mL, a prescription medication. The fixed-price contract has a ceiling value of $7,220.33 and a period of performance through August 12, 2024. As a prime contractor, AmerisourceBergen, a major pharmaceutical distributor, will be responsible for delivering the requested pharmaceutical product to support medical treatment...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical is a delivery order placed with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for TRESIBA FLEXTOUCH 100 UNIT/ML 3ML. The contract has a firm fixed price of $2,782.23 and a completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tresiba FlexTouch 200 unit/mL 3mL medication. The contract has a total ceiling value of $10,894.55 and a period of performance through July 1, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tresiba Flextouch 200 unit/mL 3mL, a diabetes medication, with a ceiling value of $4,190.98 and a period of performance through March 3, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FQF47
    Delivery Order

This is a delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Tresiba FlexTouch 100 Unit/mL 3mL, a diabetes medication. The contract has a ceiling value of $1,384.20 and a performance period extending to April 11, 2025. This award is not set-aside and represents an open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

Generated 7/17/25, 5:51 PM